ArticleFrontiers in oncology2022

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.

Kang-Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.